A Bedi
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 7
- Cancer-related Molecular Pathways 3
-
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 2
- Co-authors
- James Barber (6 shared papers)RJ Jones (6 shared papers)BA Zehnbauer (4 shared papers)SJ Sharkis (4 shared papers)Gauri C. Bedi (2 shared papers)Rajani Ravi (3 shared papers)Ephraim J. Fuchs (3 shared papers)Adil Akhtar (2 shared papers)
- Journals
- Blood (5 papers)Gastroenterology (1 paper)Journal of Clinical Oncology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)APOPTOSIS (1 paper)
- Partner nations
- United StatesEthiopiaSouth Korea
In The Last Decade
A Bedi
16 papers receiving 2.1k citations
A Bedi's Hit Papers
Peers
Comparison fields: 5 of 91
- Hematology 740
- Genetics 374
- Oncology 850
- Cancer Research 303
- Molecular Biology 882
Countries citing papers authored by A Bedi
This map shows the geographic impact of A Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bedi more than expected).
Fields of papers citing papers by A Bedi
This network shows the impact of papers produced by A Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bedi. The network helps show where A Bedi may publish in the future.
Co-authors
The 25 scholars most cited alongside A Bedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of apoptosis during development of colorectal cancer. Hit paper breakdown → | 1995 | 501 |
| 2 | 1994 | 443 | |
| 3 | 1995 | 306 | |
| 4 | 1995 | 237 | |
| 5 | p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. | 1998 | 144 |
| 6 | Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. | 2001 | 113 |
| 7 | CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. | 1998 | 106 |
| 8 | 1993 | 105 | |
| 9 | 1994 | 55 | |
| 10 | Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases. | 1996 | 53 |
| 11 | 2016 | 47 | |
| 12 | Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis. | 1995 | 46 |
| 13 | Are growth factors leukemogenic? | 1996 | 19 |
| 14 | 1998 | 13 | |
| 15 | 1993 | 10 | |
| 16 | 1995 | 2 |
About A Bedi
A Bedi is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Public Health, Environmental and Occupational Health, having authored 16 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer-related Molecular Pathways (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Acute Myeloid Leukemia Research (2 papers), NF-κB Signaling Pathways (2 papers), Cell death mechanisms and regulation (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Hematology (740 citations), Genetics (374 citations), Oncology (850 citations), Cancer Research (303 citations) and Molecular Biology (882 citations). A Bedi has collaborated with scholars based in United States, Ethiopia and South Korea. Frequent co-authors include James Barber, RJ Jones, BA Zehnbauer, SJ Sharkis, Gauri C. Bedi, Rajani Ravi, Ephraim J. Fuchs, Adil Akhtar, Francis M. Giardiello and Pankaj J. Pasricha. Their work appears in journals such as Blood, Gastroenterology, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics and APOPTOSIS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.